Multicentre study of circumferential margin positivity and outcomes following abdominoperineal excision for rectal cancer

British Journal of Surgery

Volumn 100, Issue 1, 2013, Pages 160-166

  Kennelly, R P ^a   Rogers, A C ^a   Winter, D C ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMEN; ADULT; AGED; ARTICLE; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; MELANOMA; METASTASIS; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PERITONEUM; RECTUM TUMOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ABDOMEN; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PERITONEUM; RECTAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870881223     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9001     Document Type: Article

References (29)

1. MacFarlane JK, Ryall RD, Heald RJ,. Mesorectal excision for rectal cancer. Lancet 1993; 341: 457-460.
2. den Dulk M, Marijnen CA, Putter H, Rutten HJ, Beets GL, Wiggers T, et al., Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg 2007; 246: 83-90.
3. Marr R, Birbeck K, Garvican J, Macklin CP, Tiffin NJ, Parsons WJ, et al., The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 2005; 242: 74-82.
4. Kelly SB, Mills SJ, Bradburn DM, Ratcliffe AA, Borowski DW,; Northern Region Colorectal Cancer Audit Group. Effect of the circumferential resection margin on survival following rectal cancer surgery. Br J Surg 2011; 98: 573-581.
5. Messenger DE, Cohen Z, Kirsch R, O'Connor BI, Victor JC, Huang H, et al., Favorable pathologic and long-term outcomes from the conventional approach to abdominoperineal resection. Dis Colon Rectum 2011; 54: 793-802.
6. Stelzner S, Holm T, Moran BJ, Heald RJ, Witzigmann H, Zorenkov D, et al., Deep pelvic anatomy revisited for a description of crucial steps in extralevator abdominoperineal excision for rectal cancer. Dis Colon Rectum 2011; 54: 947-957.
7. Miles WE,. A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon (1908). CA Cancer J Clin 1971; 21: 361-364.
8. Zaheer S, Pemberton JH, Farouk R, Dozois RR, Wolff BG, Ilstrup D,. Surgical treatment of adenocarcinoma of the rectum. Ann Surg 1998; 227: 800-811.
9. West NP, Finan PJ, Anderin C, Lindholm J, Holm T, Quirke P,. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 2008; 26: 3517-3522.
10. Shihab OC, Brown G, Daniels IR, Heald RJ, Quirke P, Moran BJ,. Patients with low rectal cancer treated by abdominoperineal excision have worse tumors and higher involved margin rates compared with patients treated by anterior resection. Dis Colon Rectum 2010; 53: 53-56.
11. Smith FM, Waldron D, Winter DC,. Rectum-conserving surgery in the era of chemoradiotherapy. Br J Surg 2010; 97: 1752-1764.
12. Morris EJ, Birch R, West NP, Finan PJ, Forman D, Fairley L, et al., Low abdominoperineal excision rates are associated with high-workload surgeons and lower tumour height. Is further specialization needed? Colorectal Dis 2011; 13: 755-761.
13. Guillem JG, Chessin DB, Cohen AM, Shia J, Mazumdar M, Enker W, et al., Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann Surg 2005; 241: 829-836.
14. Reshef A, Lavery I, Kiran RP,. Factors associated with oncologic outcomes after abdominoperineal resection compared with restorative resection for low rectal cancer: patient- and tumor-related or technical factors only? Dis Colon Rectum 2012; 55: 51-58.
15. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Søreide O,; Norwegian Rectal Cancer Group. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum 2004; 47: 48-58.
16. Dehni N, McFadden N, McNamara DA, Guiguet M, Tiret E, Parc R,. Oncologic results following abdominoperineal resection for adenocarcinoma of the low rectum. Dis Colon Rectum 2003; 46: 867-874.
17. Mathis KL, Larson DW, Dozois EJ, Cima RR, Huebner M, Haddock MG, et al., Outcomes following surgery without radiotherapy for rectal cancer. Br J Surg 2012; 99: 137-143.
18. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, et al.,; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
19. Carlsen E, Schlichting E, Guldvog I, Johnson E, Heald RJ,. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg 1998; 85: 526-529.
20. Heald RJ, Ryall RD,. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: 1479-1482.
21. Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, et al., A national strategic change in treatment policy for rectal cancer - implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002; 45: 857-866.
22. Martin ST, Heneghan HM, Winter DC,. Systematic review of outcomes after intersphincteric resection for low rectal cancer. Br J Surg 2012; 99: 603-612.
23. Holm T, Ljung A, Haggmark T, Jurell G, Lagergren J,. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 2007; 94: 232-238.
24. West NP, Anderin C, Smith KJ, Holm T, Quirke P,; European Extralevator Abdominoperineal Excision Study Group. Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg 2010; 97: 588-599.
25. Beddy D, Hyland JM, Winter DC, Lim C, White A, Moriarty M, et al., A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy. Ann Surg Oncol 2008; 15: 3471-3477.
26. Martin ST, Heneghan HM, Winter DC,. Systematic review and meta-analysis of outcomes following pathological complete response to neoadjuvant chemoradiotherapy for rectal cancer. Br J Surg 2012; 99: 918-928.
27. Osler M, Iversen LH, Borglykke A, Martensson S, Daugbjerg S, Harling H, et al., Hospital variation in 30-day mortality after colorectal cancer surgery in Denmark: the contribution of hospital volume and patient characteristics. Ann Surg 2011; 253: 733-738.
28. Iversen LH, Harling H, Laurberg S, Wille-Jorgensen P,. Influence of caseload and surgical speciality on outcome following surgery for colorectal cancer: a review of evidence. Part 1: short-term outcome. Colorectal Dis 2007; 9: 28-37.
29. Lim SB, Yu CS, Hong YS, Kim TW, Kim JH, Kim JC,. Long-term outcomes in patients with locally advanced rectal cancer treated with preoperative chemoradiation followed by curative surgical resection. J Surg Oncol 2012; 106: 659-666.